Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1998
11/19/1998WO1998051820A1 METHODS FOR MEASURING CELLULAR PROLIFERATION AND DESTRUCTION RATES IN VITRO AND $i(IN VIVO)
11/19/1998WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
11/19/1998WO1998051708A1 A method for the improvement of neuronal regeneration
11/19/1998WO1998051702A1 Methods and compositions for destruction of selected proteins
11/19/1998WO1998051692A1 Acyclovir diester derivatives
11/19/1998WO1998051689A1 A new process for the preparation of a pharmacologically active substance
11/19/1998WO1998051688A1 6-SUBSTITUTED 1,2,4a,5a,8a,8b HEXAHYDRO- AND 1,2,3,4,4a,5a,8a,8b-OCTAHYDRO-6H-PYRROLO [3',4':4,5]FURO[3,2-b]PYRID-8(7H)-ON DERIVATIVES AND THEIR USE IN COMBATTING ENDOPARASITES
11/19/1998WO1998051687A1 Piperidino derivatives which promote growth hormone release
11/19/1998WO1998051686A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
11/19/1998WO1998051684A1 Antithrombotic compound
11/19/1998WO1998051679A1 Tocopherol esters and their cosmetic and pharmaceutical uses
11/19/1998WO1998051678A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
11/19/1998WO1998051676A1 Efficient enantioselective addition reaction using an organozinc reagent
11/19/1998WO1998051671A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/19/1998WO1998051669A1 Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp
11/19/1998WO1998051668A1 Piperidine derivatives as neurotransmitter re-uptake inhibitors
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051664A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998WO1998051663A2 3-epi compounds of vitamin d3 and uses thereof
11/19/1998WO1998051662A2 Compounds and methods for the inhibition of the expression of vcam-1
11/19/1998WO1998051655A1 Excitatory amino acid receptor modulators
11/19/1998WO1998051408A1 Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties
11/19/1998WO1998051349A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998WO1998051344A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998WO1998051342A1 Substrates materials with bound cytokine-stimulating polysaccharides or bacterial nucleic acids
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051334A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
11/19/1998WO1998051330A1 Method and compositions for treating hyperlipidemia and other conditions
11/19/1998WO1998051321A1 Tissue factor for influencing blood vessel formation
11/19/1998WO1998051315A1 Therapeutic agent for articular rheumatism
11/19/1998WO1998051314A1 Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder
11/19/1998WO1998051313A1 Remedies for dry eye
11/19/1998WO1998051311A2 Dihydropyrimidines and uses thereof
11/19/1998WO1998051310A1 A method for the treatment of mental illness in mammals and a composition therefor
11/19/1998WO1998051309A1 Use of serotonin agonists to alleviate disordered breathing episodes in a mammal
11/19/1998WO1998051308A1 METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS
11/19/1998WO1998051307A1 METHODS FOR TREATING INFLAMMATION, INFLAMMATORY DISEASES, ARTHRITIS AND STROKE USING pADPRT INHIBITORS
11/19/1998WO1998051306A1 Medicinal compositions against helicobacter pylori
11/19/1998WO1998051305A1 Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes
11/19/1998WO1998051304A1 Benzimidazole-2-carbamates for the treatment of viral infections and cancer
11/19/1998WO1998051303A1 Hiv and cancer treatment
11/19/1998WO1998051302A1 Composition and methods for treating alzheimer's disease and other amyloidoses
11/19/1998WO1998051301A1 Use of indolamines as antithrombotic medicine
11/19/1998WO1998051300A1 Treatment of allergic conditions
11/19/1998WO1998051299A1 Patches containing isosorbide nitrate
11/19/1998WO1998051298A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
11/19/1998WO1998051297A1 Inhibition of cell surface protein disulfide isomerase
11/19/1998WO1998051295A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions
11/19/1998WO1998051294A2 Method and composition for treating cancers
11/19/1998WO1998051293A1 Use of betulinic acid derivatives for the treatment and prevention of melanoma
11/19/1998WO1998051292A1 Sympathomimetic compounds
11/19/1998WO1998051291A1 Use of a pharmaceutical composition for treating and/or preventing ischemia
11/19/1998WO1998051290A2 Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
11/19/1998WO1998051289A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998WO1998051283A1 Topical compositions
11/19/1998WO1998051280A1 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs
11/19/1998WO1998051279A2 Method of making microencapsulated dna for vaccination and gene therapy
11/19/1998WO1998051278A2 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
11/19/1998WO1998051277A1 Medical uses of pyruvates
11/19/1998WO1998051273A1 Topical spray for burn treatment and anti-infection
11/19/1998WO1998051266A1 Fixative polymers
11/19/1998WO1998051246A1 Methods and devices for delivering opioid analgesics to wounds
11/19/1998WO1998051244A1 Intrauterine chemical necrosing method, composition, and apparatus
11/19/1998WO1998051164A1 Feed composition for broilers and method for breeding broilers
11/19/1998WO1998040058A3 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
11/19/1998WO1998037089A3 Matrix derived anti-hiv peptides and transdominant proteins
11/19/1998WO1998036741A3 Use of 2-desoxyglucose for suppressing viral transcription
11/19/1998WO1998035061A3 Member of the tnf family useful for treatment and diagnosis of disease
11/19/1998WO1998034584A3 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
11/19/1998WO1998033929A3 Use of a polypeptide as cell receptor for adenoviruses
11/19/1998WO1998033896A3 Microorganisms with increased production of clavulanic acid
11/19/1998WO1998033490A3 Use of percaboxylic acids in the control of hairy wart disease
11/19/1998WO1998026062A3 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
11/19/1998DE19821073A1 New sulphated vinyl (co)polymer heparin analogues
11/19/1998DE19720339A1 Treatment or prevention of undesired skin pigmentation
11/19/1998DE19719839A1 6-Substituierte 1,2,4a,5a,8a,8b-Hexahydro- und 1,2,3,4,4a,5a,8a,8b-Oktahydro-6H-pyrrolo/3',4':4,5/furo/3,2-b/pyrid-8(7H)-on Derivate und ihre Verwendung zur Bekämpfung von Endoparasiten 6-Substituted 1,2,4a, 5a, 8a, 8b-hexahydro- and 1,2,3,4,4a, 5a, 8a, 8b-octahydro-6H-pyrrolo / 3 ', 4': 4,5 / furo / 3,2-b / pyrid-8 (7H) -one derivatives and their use for controlling endoparasites
11/19/1998DE19719680A1 Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz Use of diphosphonic acids for the preventive treatment of sequelae in bladder extension or bladder replacement
11/19/1998CA2428130A1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998CA2290021A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998CA2290005A1 Inhibition of cell surface protein disulfide isomerase
11/19/1998CA2289969A1 Acyclovir diester derivatives
11/19/1998CA2289966A1 Topical compositions
11/19/1998CA2289704A1 Medical uses of pyruvates
11/19/1998CA2289686A1 Use of betulinic acid derivatives for the treatment and prevention of melanoma
11/19/1998CA2289684A1 Method and composition for treating cancers
11/19/1998CA2289625A1 Antithrombotic compound
11/19/1998CA2289573A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
11/19/1998CA2289550A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
11/19/1998CA2289450A1 6-substituted 1,2,4a,5a,8a,8b hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6h-pyrrolo [3',4':4,5]furo[3,2-b]pyrid-8(7h)-on derivatives and their use in combatting endoparasites
11/19/1998CA2289448A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998CA2288850A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/19/1998CA2288710A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998CA2288627A1 Feed composition for broilers and method for breeding broilers
11/19/1998CA2288117A1 Tissue factor for influencing blood vessel formation
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998CA2287363A1 Use of a pharmaceutical composition for treating and/or preventing ischemia
11/19/1998CA2286875A1 Chemical compounds
11/19/1998CA2282473A1 Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes
11/19/1998CA2268848A1 Hiv and cancer treatment
11/19/1998CA2259425A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions
1 ... 6578 6579 6580 6581 6582 6583 6584 6585 6586 6587 6588 6589 6590 6591 6592 6593 6594 6595 6596 6597 6598 ... 7860